Cancer treatment

It is a cancer caused by the inhalation of asbestos dust, and is the most rare of mesothelioma cancers. It accounts for about 5% of all cases.
Its period of latency (time it takes for the symptoms to show) is approximately 30-50 years. Symptoms are similar to other diseases such as pneumonia whilst in the early stages. This makes it rather difficult to diagnose and treat.

What are the treatment options for pericardial mesothelioma?

There are three options available for an individual diagnosed with this cancer; surgery, radiation and chemotherapy. A patient will first require a doctor’s evaluation to determine which treatment option is suitable for him.

What are my chances of survival from pericardial mesothelioma?

It is important to stress that once you start experiencing the symptoms of pericardial mesothelioma (shortness of breath, chest pains, coughing up blood, and palpitations) you should immediately seek specialized help.
The prognosis of pericardial mesothelioma depends largely on how early the cancer is detected. Should you be diagnosed in the later stages of development, your chances of survival could be very slim (usually a few months).

Can you go through each of the treatment options?

Radiation - large doses of radiation are used to kill the cancerous cells on the pericardium. The disadvantage of using radiation to treat pericardial mesothelioma is that the vital organs close to the heart are also being damaged.

Surgery - this can be divided into two parts; aggressive surgery & palliative procedures. Aggressive surgery involves the removal of the cancerous cells from the pericardium. This procedure is only performed by an extremely skilled surgeon as the cells are usually located in close proximity to the heart and lungs. Any small mishap can have a fatal outcome.

Palliative procedures are used in the latest stages of pericardial mesothelioma. They serve the sole purpose of relieving the symptoms since the cancer is almost incurable at this stage.

Chemotherapy - drugs are used to kill the cancerous cells. Unfortunately, the majority of drugs used to treat pericardial mesothelioma have an extremely low success rate. Pharmaceutical companies are conducting trials to come up with the right combination of drugs that can produce better results for treating pericardial mesothelioma.

Mesothelioma is a cancer primarily focused on the cells surrounding the lungs. This cancer has been associated exclusively with the exposure to asbestos which was commonly used in industrial and residential uses up until the late 1970’s. Many people who were exposed to this material have suffered the devastating consequences and have joined together to file moseothelioma related lawsuits against former employers and manufacturers of asbestos.

If you believe you are suffering from this deadly disease you should carefully review the options available to you before deciding to join a joint lawsuit or class-action case. In many cases these types of lawsuits take years to settle and the victims will actually receive very little of the money, if any, awarded. Most of the money goes towards lawyer fees and court costs.

When you decide to pursue legal action it is best to start with a local attorney or family attorney if one is available. Ask them for referrals to other attorneys that handle these types of cases. They will most often know reputable lawyers who are out to help the victims instead of make profit off of other’s suffering. Remember, lawsuits of this nature may take several years to be resolved. If you are suffering serious medical problems currently it is strongly recommended that you focus your energy on fighting this awful cancer and worrying about lawsuits after you have regained some of your strength.

A melanoma is a cancerous tumor that starts in melanin-generating cells (color-giving pigment). Once thought of as a rare disease, the yearly frequency of melanoma has increased noticeably.

Extreme exposure to sun is one major reason for contracting this disease. People who regularly expose themselves to the sun during peak mid-day hours, without adequate protection, are at a greater risk of getting melanoma. Exposure to the sun at a younger age puts you at risk throughout your lifetime.

Melanoma normally occurs on parts of the body receiving irregular sun exposure. This condition generally affects fair-skinned people. Not surprisingly, people from regions having sunny climates have greater chances of being affected by this disease.

However, sun exposure is not the sole way of developing this form of skin cancer; it can be genetic as well. Some people have a specific type of skin that engenders moles susceptible to the disease. Also, melanomas can occur on the areas of the body that get little or no sun exposure.

Dysplastic nevus syndrome, commonly called atypical mole syndrome, rarely affects the Caucasian population. There are two known forms of atypical mole syndrome. One is a hereditary atypical mole; the other is called melanoma syndrome. In the first case, members of a family will spot vast numbers of moles on their bodies. In the second instance, someone may just happen to have a lot of moles over his body, without it being a familial trait.

Generally, people do not get moles after the age of thirty; also, it is common for moles to fade away with age. When children about the age of five have moles on the hip, buttock or scalp, it should be seen as a warning indication. It is highly uncommon for a child to get skin cancer, yet some children have been fatally affected by it. Young people can be seriously affected by this form of cancer if not diagnosed and treated early.

A melanoma is a malignant tumor that originates in melanocytes, which are cells responsible for generating melanin (pigment that gives color to skin, hair and eyes and is strongest in moles). Melanomas, therefore, are generally brown or black. Sometimes, melanomas stop generating pigment. In such cases, the melanomas are red, pink, purple or skin-colored.

Melanomas can be in situ or invasive. In situ in Latin means “localized.” These types of melanomas occupy only the top layer of the skin. Invasive melanomas are far more serious and difficult to cure. They go much deeper into the skin, having traveled through the body.

Melanomas are divided into four broad groups. Three start in situ and later become invasive; the fourth form of melanoma is invasive from the beginning.

Superficial spreading melanoma is the most prevalent type of melanoma. 70% of all reported cases are superficial spreading melanoma. This melanoma occupies the top layer of the skin for a long time before being invasive. Melanomas affecting the younger age group are normally the superficial type.

Lentigo maligna is similar, in that it also affects the top layer of the skin for a long time before going deeper. The older age group is mostly affected by this type of melanoma. This condition can take place in the ears, arms and upper trunk, if they have been constantly exposed to the sun. Lentigo maligna melanoma is considered to be an invasive form of the disease.

Acral lentiginous melanoma is the third form of melanoma, and like the first two it spreads along the top surface before tuning invasive. Acral lentiginous melanoma is sometimes found in people of darker skin. It is more prevalent among Asians and African-Americans than Caucasians.

Nodular melanoma, the fourth type of melanoma, is easily the most aggressive. It is invasive at the time of diagnosis. The most commonly affected areas are arms, legs, trunks (especially of older people) and the scalp. Nodular melanoma constitutes 10% to 15% of all melanoma cases.

Malignant melanomas are typified by brown, black or big bright patches, and nodules with uneven outline. They sit on top of the skin surface or bleed. Mostly, they originate in already existing moles. Melanoma generally targets the trunk in men. In women, arms and lower legs are affected.

Melanoma is known to be genetic as well. In some families, people have “dysplastic nevi” or strange-looking moles that are more liable to turn cancerous than others. It is imperative for those people to have regular checkups for detection of cancerous cells.

Mesothelioma is an uncommon form of cancer that takes place in the mesothelium. The mesothelium is made up of visceral and parietal membranes which surround organs and body cavities, such as the lungs or abdomen. The visceral membrane immediately surrounds the organ, and the parietal membrane is a sac covering the visceral membrane. There is a lubricating fluid between these membranes that make up the mesothelium. This fluid helps organs move easily between surrounding structures. In the case of the lung, it helps reduce friction between the lung and chest wall during normal breathing as the lung expands.

Here are more facts about mesothelioma:

There are different types of mesothelioma
In the abdomen, it is called peritoneal mesothelioma; on the lungs, it is called pleural mesothelioma; and if it develops on the heart, pericardial mesothelioma.

It develops mostly on the lungs:

The most common location for mesothelioma to develop is on the lungs. About two-thirds of all mesothelioma cases develop in the pleural mesothelium. This mesothelioma on the lungs is called malignant pleural mesothelioma (MPM). The remaining cases develop in the peritoneal mesothelium in the abdomen. A tumor in the abdominal mesothelium is called peritoneal mesothelioma. Rarely, mesothelioma occurs in other mesothelial tissue, such as on the heart or on the reproductive organs.

It may have other causes:

Although asbestos is the major cause of mesothelioma, up to 30–50% of all cases are not clearly related to previous asbestos exposure. Other possible reasons include previous exposure to radiation or to particular minerals closely related to asbestos that are found in the soil. Smoking has not been shown to be a cause of mesothelioma. However, if a smoker has also been exposed to asbestos, this significantly increases his or her risk of developing other types of lung cancer.

It has a long development time:

It has a long latency period, which means that symptoms don’t develop for 20–50 years after environmental exposure. The average age at which symptoms usually start to appear is around 60 years old.

It occurs more in men than in women:

Mesothelioma affects men about three times more often than women in the US. Occurrence rises gradually with age. In other parts of the world, where exposure comes primarily from other environmental sources, such as in Turkey, mesothelioma occurs about equally in men and women.

In spite of the rapid growth of technology and the bright discoveries of the medical fraternity, the treatment of mesothelioma has been far from successful. Conventional therapies have somewhat flopped, and patients survive twelve months, at an average, after being found out having the disease. The following are the options available for a person with mesothelioma:

One is surgery, either by itself, or in conjunction with pre-operative or post-operative therapies. However, this has only a 5-year survival rate of less than 10% of those affected by the disease.

The tumor is extremely resistant to chemotherapy and radiotherapy; yet these methods are sometimes deployed to alleviate symptoms caused by tumor metastases, like obstruction of a blood vessel.

Treatment methods that involve immunotherapy have brought about inconsistent results. For instance, “intra-pleural immunization” of Bacillus Calmette-Guerin (BCG) to enhance the immune response was found to be of no advantage to the mesothelioma patient. However, those suffering from bladder cancer have benefited from this treatment. Patients undertaking this specific therapy felt major side effects, like fever and cachexia. Nevertheless, other methods using “interferon alpha” have proven to be more effective, with a fifth of all tested mesothelioma patients experiencing more than half the reduction in tumor mass, with few side effects.

Then there is another procedure called “heated intraoperative intraperitoneal chemotherapy”. It was discovered by a surgeon named Paul Sugarbaker, of the Washington Cancer Institute. In this method, the surgeon takes out as much of the tumor mass as possible. This is subsequently followed by using a chemotherapy agent (at about 40 to 48°C) in the abdomen. The agent (a fluid) is inserted for an hour to two hours before being drained. This method allows for the usage of high concentrations of specific drugs into the pelvic surfaces. It also facilitates greater penetration of the medicines into the cancer tissues. Also, heating adversely affects malignant cells more than normal cells.

Let us take the scenario of a seventy-year-old man, who is a nonsmoker and otherwise fairly healthy, approaching the local doctor with complaints of persistent cough, chest congestion and weight loss. Other symptoms may include difficulty in swallowing and loss of appetite. The physician has several options of diagnosis, but pleural mesothelioma, a lethal cancer that originates in the lining enveloping the lungs, may not be considered.

There are several reasons for this. Recognition of pleural mesothelioma as a separate disease entity started as recently as the 1960s. Currently only about 3000 cases are reported annually in the United States. Many doctors may not have seen a single such case during their career. The symptoms are similar to many lesser afflictions. The only general lead is that the disease seems to be more prevalent in the Pacific and Mid-Atlantic States. It is also known that the major cause for pleural mesothelioma is exposure to asbestos. But how much contact with the material leads to this disease is unclear. Even the family members of an asbestos worker are at risk from the dust he carries home on his body and clothing.

This form of cancer has a long latent period and the symptoms manifest only twenty to forty or more years after exposure to asbestos. This also vitiates the possibility of correct diagnosis.

Once the doctor eliminates the chances of other diseases and pursues the pleural mesothelioma line, the patient is subjected to a battery of tests and imaging procedures like x-ray and CT scan. Fluid collection in the thoracic cavity is an indicator, but not conclusive. Confirmation can be obtained with a pleural (pleura is the membrane covering the lungs) biopsy using an electron microscope.

Since pleural mesothelioma is an aggressive cancer, early detection and immediate introduction of appropriate management are of critical importance. The possibility of a doctor who fails to diagnose pleural mesothelioma or misdiagnoses it, being sued for medical malpractice cannot be totally ruled out. But usually the law applicable is asbestos product liability.

It is generally accepted that pleural mesothelioma is a disease that is difficult to diagnose. To help the doctor, the patient should inform him at the very outset about exposure to asbestos, if any.

Mesothelioma is a form of cancer that affects the abdominal cavity, chest cavity, and the area around the heart. It has an uncommon nature that makes it difficult to diagnose and treat. It has been connected with exposure to asbestos, which is a material that was found in many work environments. There is a small amount of people that are diagnosed with this terrible disease.

Normal mesothelioma therapies include surgery, radiation and chemotherapy. You should keep in mind that if you choose one course of action for mesothelioma treatment, you might preclude other courses. All of your options should be considered as soon as possible.

When individuals have a prolonged history of working with asbestos, they are at higher risk of Mesothelioma cancer. It will take the people that have been exposed to this type of asbestos to not have any kind of symptoms for up to forty years. This means that the average age of the people that are finding out that they have this problem are between the ages of fifty and seventy. There are more men that are being diagnosed than women. This is due to the fact that there were more industrial settings found to have the asbestos.

Mesothelioma cancer will cause fluid to accumulate between the lung lining and the chest cavity. This can be determined through a chest x-ray as well as a CT scan. A biopsy will have to be performed to confirm the diagnoses.

Mesothelioma cancer is a life threatening disease and should not be left untreated. If someone had this type of cancer, they need to seek the help of a medical professional as soon as possible. There are forms of treatment that have to be set into place so that the person has a chance at their life.

In recent years asbestos has not been used in anything. Since it has been determined that it is so dangerous to one’s health, the federal government has forbad the use of this type of material in any industry or products. A lot of the industries in the fifties and sixties were contaminated with asbestos that caused many people to have mesothelioma cancer.

Many sources are dedicated to help the victims of this awful disease. Many agencies are going to great lengths to help the people that have been affected and the families that have had to suffer because of this terrible disease. Even though this is a rare disease, it can affect thousands of families each year.

Some of the treatments of Mesothelioma cancer include surgery, radiation and chemotherapy. You need to keep in mind that if you choose one course of treatment for this disease, you may have to take on another challenge or even try another form of treatment for it to work. You must keep going and try all that is offered to ensure that you beat this terrible disease.

Majority of mesothelioma (cancerous tumor affecting mesothelial cells of organs) cases come under the classification ‘pleural mesothelioma’. This is a cancer that originates in the pleura, the delicate membrane covering the lungs. Out of these, seventy five percent are diffuse malignant pleural mesethelioma. The balance is localized or benign.

Diffuse malignant pleural mesothelioma is, in most cases, caused by unprotected exposure to asbestos. The symptoms include shortness of breath and/or chest pain, loss of weight, cough, fatigue, swelling on the face, neck and arms, reduced appetite, and coughing up blood. There would be collection of fluid in the thoracic cavity. It may take from twenty to forty years or more after contact with asbestos for the symptoms to emerge. Because of the time lag, diagnosing is often difficult. Moreover, many doctors are not familiar with the disease.

Diagnostic procedure consists mostly of imaging with Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI) and Position Emission Tomography (PET), and laboratory tests and analysis. Thoractomy, which means making an incision through the chest wall to look into the pleura (the membrane lining the lungs and the thoracic cavity) and pleural biopsy provide conclusive evidence.

Diffuse malignant pleural mesothelioma tumor is very aggressive and spreads fast. There are several methods to gauge the stage of the cancer. The most common is known as TNM. T is for the size of the tumor, N for the number of lymph nodules involved, and M for metastasis (spread of the cancer). There are basically four different stages. Correct grading helps the doctors to decide on the course of treatment. If the affliction is detected at an early stage, the chances of longer survival are better.

But generally the prognosis (response to treatment) is not good in diffuse malignant pleural mesothelioma cases. Surgery during Stage I may help. If detected during the later phases of the cancer the survival rate is four months to twelve months. Radiotherapy and chemotherapy do not seem to improve the survival rate. The reality is that currently there is no effective curative treatment. Research is on to find new management methods and more effectual medicines.

Malignant Pleural Mesothelioma is a lethal cancer that starts in the lining of the lungs. The main cause is believed to be unprotected contact with asbestos. Every year about 3000 new cases of this disease are reported in the United States. It is estimated that over the past fifty years nearly eight million people have been exposed to asbestos and that 300,000 new cases would be reported by the year 2030. The peak may be around 2020 and thereafter the incidence is likely to taper down because of the preventive measures that are being taken.

Like in all cases of cancer, early detection and appropriate treatment improve the survival rate. On both counts the pleural mesothelioma patients are at a disadvantage. Symptoms take anywhere between 20 to 50 years to manifest. Because of this, the patients are generally in the fifty plus age group. And the outwardly noticed indications of the sickness are similar to that of several lesser ailments. This makes the diagnosis difficult. Because of all these, by the time the problem is detected, the cancer is likely to have spread. As yet there is no fully effective line of treatment. It is generally accepted that a combination therapy is better than monotherapy. A great deal of research is being done in this area.

A number of studies have been made about the survival rate among pleural mesothelioma patients. They all come to the same conclusion – the disease is almost always fatal. The lifespan of a person diagnosed with pleural mesothelioma is about six months to two years. There have been exceptions and their stories are inspiring. The life expectancy varies according to the stage (pleural mesothelioma has four different phases) and the type. One research based on the histologic (tissue structure)tests shows a median survival of 11 months – 9.4 months for sarcomatous, 12.5 months for epithelial and 11 months for mixed.